Thyrocare expands presence in Madurai with launch of new diagnostic laboratory

Thyrocare Technologies has announced the launch of its new diagnostic laboratory in Madurai, Tamil Nadu. The facility was inaugurated by Rahul Guha, Managing Director & CEO, Thyrocare and API Holdings. The launch marks another step in Thyrocare’s efforts to strengthen its diagnostic network and improve access to reliable and affordable diagnostic services across emerging markets.

The new laboratory is equipped to cater to routine as well as specialised diagnostic testing requirements and is supported by trained professionals and Thyrocare’s technology-enabled diagnostic processes. The facility is expected to support the growing healthcare needs of patients, laboratories and healthcare partners across Madurai and the surrounding regions.

The expansion strengthens Thyrocare’s local presence in Tamil Nadu and enables greater access to its diagnostic services, supported by standardised processes, timely sample processing and reliable reporting.

The launch is also aligned with the company’s continued focus on expanding its network beyond key metropolitan markets and bringing quality diagnostic services closer to patients.

Sharing his thoughts on the launch, Rahul Guha, Managing Director & CEO, Thyrocare and  API Holdings, said, “At Thyrocare, our focus has always been on making quality and trustworthy diagnostic services more accessible to people across India. The launch of our new laboratory in Madurai is another step towards strengthening our presence in emerging markets and bringing our technology-led diagnostic capabilities closer to patients."

With the launch of its new laboratory in Madurai, Thyrocare continues to strengthen its diagnostic footprint across India, with a focus on expanding access to standardised and affordable testing beyond the metro markets.